Your browser doesn't support javascript.
loading
Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
Lorenzo-Villalba, Noel; Andres, Emmanuel; Guerrero-Niño, Javier; Nasco, Edward; Cattelan, Jessy; Jannot, Xavier; Ledoux, Marie-Pierre.
Afiliação
  • Lorenzo-Villalba N; Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
  • Andres E; Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
  • Guerrero-Niño J; Service des Urgences, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
  • Nasco E; Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
  • Cattelan J; Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
  • Jannot X; Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
  • Ledoux MP; Service d'Hématologie, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Medicina (Kaunas) ; 57(6)2021 Jun 08.
Article em En | MEDLINE | ID: mdl-34201186
ABSTRACT
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the patient presented with necrotic cutaneous lesions in both hands and distal lower extremities. Upon admission, hemoglobin was 7.6 g/dL and laboratory tests were consistent with cold agglutinin disease (CAD), the presence of monoclonal IgM, and flow cytometry consistent with lymphoplasmacytic lymphoma, but MYD88 L265P mutation was negative. The patient required blood transfusion, resulting in stabilized hemoglobin and a decrease in markers of hemolysis. Treatment with aspirin 250 mg daily and intravenous iloprost 0.5 mL/h was initiated with a poor clinical response at day 4. Amputation was required. Plasma exchange was performed and chemotherapy with rituximab and bendamustine was initiated. The clinical course was marked by further necrosis, prompting discussions regarding an additional amputation that was not performed considering the high surgical risk and refusal by the patient. Supportive treatment was initiated, and the patient expired one month after hospital admission.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom / Congelamento das Extremidades / Anemia Hemolítica Autoimune Tipo de estudo: Diagnostic_studies Limite: Aged80 / Female / Humans Idioma: En Revista: Medicina (Kaunas) Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom / Congelamento das Extremidades / Anemia Hemolítica Autoimune Tipo de estudo: Diagnostic_studies Limite: Aged80 / Female / Humans Idioma: En Revista: Medicina (Kaunas) Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França